However, for HR-positive primary BCs which gave rise to distant metastases, only PR expression was significantly associated with HER2 status changes: a lower PR expression (ER+/PR- tumours) seemed to favour a change from HER2-negativity in the primary tumour to HER2-low status in the recurrence. This evidence concerns the gene ERBB2 and neoplasm.